LONDON and SALT LAKE CITY, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will report its first quarter fiscal year 2023 financial results on Wednesday, November 30, 2022, before market open. The Company will host a corresponding conference call and

RNS Number : 1356H Renalytix PLC 22 November 2022       Renalytix plc ("Renalytix" or the "Company")   Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30   LONDON and SALT LAKE CITY , November 22, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that

RNS Number : 9096F Renalytix PLC 10 November 2022     Renalytix plc ("Renalytix" or the "Company")   Publication of Annual Report 2022 and Notice of 2022 Annual General Meeting   LONDON and SALT LAKE CITY, UT   November 10, 2022 -   Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual

RNS Number : 8850F Renalytix PLC 09 November 2022   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

NEW YORK and SALT LAKE CITY, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will participate in the Stifel Healthcare Conference to be held November 15-16, 2022 at the Lotte New York Palace Hotel.

RNS Number : 1206F Renalytix PLC 03 November 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix   to Present at Stifel Healthcare Conference   NEW YORK, NY and SALT LAKE CITY, UT    ̶  November 3, 2022   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will

RNS Number : 7950E Renalytix PLC 31 October 2022   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

RNS Number : 7941E Renalytix PLC 31 October 2022   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

LONDON and SALT LAKE CITY, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based

RNS Number : 5791E Renalytix PLC 31 October 2022   Renalytix plc (" Renalytix ", the "Group" or the " Company ")   Renalytix Reports Full Year Fiscal 2022 Results   LONDON and SALT LAKE CITY , October 31, 2022   -  Renalytix plc   (NASDAQ: RNLX),  (LSE : RENX)   an artificial intelligence-enabled